Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Commercial
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Clinical
EMA issues advice on casirivimab and imdevimab antibody cocktail for the…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Clinical
Incyte Announces the Validation by the European Medicines Agency of its…
Commercial
Assembly Biosciences and Arbutus Biopharma Initiate Phase 2 Clinical Trial of…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Abcam to Report Interim Results on Monday, March 8, 2021
Clinical
Roche SARS-CoV-2 Rapid Antigen Test receives special approval for at-home patient…
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Commercial
Albireo Spotlights Global Patient Communities on Rare Disease Day Nasdaq:ALBO
Home
Commercial
Acquisitions
Acquisitions
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Acquisitions
Amneal Reports Fourth Quarter and Full Year 2020 Financial Results
Biospace News
-
February 26, 2021
Acquisitions
4D Pharma Announces U.S. SEC Declares Registration Statement Effective with Respect to the Issuance of 4D Pharma American Depositary Shares on NASDAQ
Acquisitions
Takeda to Divest Four Diabetes Products in Japan to Teijin Pharma Limited
Acquisitions
Olainfarm Group lays a strong foundation for sustainable development Riga Stock Exchange:OLF1R
Acquisitions
Vicore Pharma Holding AB (publ) publishes the year-end report for 2020
Acquisitions
Zogenix Provides Corporate Update and Reports Fourth Quarter and Full-Year 2020...
Firstwordpharma News
-
February 26, 2021
0
Acquisitions
Assembly Biosciences Reports Fourth Quarter and Year End 2020 Financial Results...
Globenewswire News
-
February 25, 2021
0
Acquisitions
Collegium Reports Record Full-Year 2020 Revenue of $310.0 Million Nasdaq:COLL
Globenewswire News
-
February 25, 2021
0
Acquisitions
Merck to Acquire Pandion Therapeutics
-
February 25, 2021
0
Acquisitions
10x Genomics Announces New Product Lineup and Tetramer Shop Acquisition
Biospace News
-
February 25, 2021
0
1
2
3
...
40
Page 1 of 40
- Advertisement -
MOST POPULAR
Harmony Biosciences Certified As A Great Place To Work In An...
February 4, 2019
Neuralstem Announces Publication of Results from Phase 1 Clinical Trial Evaluating...
July 1, 2019
GenFit Moves Lead Candidate into Another Phase III Trial with Breakthrough...
April 24, 2019
RM LAW Announces Class Action Lawsuit Against Lexicon Pharmaceuticals, Inc.
February 8, 2019
Load more
HOT NEWS
Clinical
Voyager Takes a Hit After FDA Places Hold on Gene Therapy...
Commercial
Nicox Selects Development Candidate in a New Class of NO-mediated Intraocular...
Others
Hoth Therapeutics to Present at the 9th Annual LD Micro Invitational...
Phase I
CLR 131 Achieves 50% Overall Response Rate in Cohort 6 of...
